1
Eric First, M.D.
Eric R First: toxin treatment for kinesia. Allergan, Claude L Nassif, Stephen Donovan, Martin A Voet, September 18, 2007: US07270287 (15 worldwide citation)

Methods for treating kinesia (motion sickness) by local administration of a Clostridial toxin, such as a botulinum toxin, to a cranial or neck area of a patient susceptible to motion sickness.


2
Eric First, M.D.
Eric R First: Methods and compositions for treating eye disorders. Allergan, Claude L Hassif, Stephen Donovan, Martin A Voet, May 22, 2007: US07220422 (7 worldwide citation)

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


3
Stephen Donovan, Daniel G Brady: Neurotoxin implant. Allergan Sales, Martin A Voet, Robert J Baran, Carlos A Fisher, October 23, 2001: US06306423 (281 worldwide citation)

A biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years. The implant can be made of casting a solution of a polymer, such as an ethyl vinyl acetate copolymer and the neurotoxin. The neurotoxin can be a botulinum toxin.


4
Stephen Donovan: Botulinum toxin implant. Allergan Sales, Martin A Voet, Robert J Baran, Carlos A Fisher, November 6, 2001: US06312708 (201 worldwide citation)

A controlled release system for multiphasic, in vivo release of therapeutic amounts of botulinum toxin in a human patient over a prolonged period of time. The controlled release system can comprise a plurality of botulinum toxin incorporating polymeric microspheres.


5
Stephen Donovan, Daniel G Brady: Biodegradable neurotoxin implant. Allergan Sales, Martin A Voet, Robert J Baran, Carlos A Fisher, May 7, 2002: US06383509 (185 worldwide citation)

A biocompatible implant for continuous in vivo release of a neurotoxin over a treatment period extending from one month to five years. The implant can be made of casting a solution of a polymer, such as an ethyl vinyl acetate copolymer and the neurotoxin. The neurotoxin can be a botulinum toxin.


6
Roshantha A S Chandraratna: Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity. Allergan, Gabor L Szekeres, Martin A Voet, Robert J Baran, February 18, 1992: US05089509 (179 worldwide citation)

Retinoid-like activity is exhibited by compounds of the formula ##STR1## where X is S, O, or NR' where R' is hydrogen or lower alkyl; R is hydrogen or lower alkyl; A is pyridyl, thienyl, furyl, pyridazinyl, pyrimidinyl or pyrazinyl; n is 0-2; and B is H, --COOH or a pharmaceutically acceptable salt, ...


7
David F Woodward, Steven W Andrews, Robert M Burk, Michael E Garst: Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents. Allergan, Robert J Baran, Martin A Voet, Howard R Lambert, November 18, 1997: US05688819 (162 worldwide citation)

The present invention provides cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compounds, which may be substituted in the 1-position with amino, amido, ether or ester groups, e.g., a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) compound. The cyclopentane heptanoic acid, 2-(cy ...


8
Vithal Jagannath Rajadhyaksha: Vehicle composition containing 1-substituted azacycloheptan-2-ones. Nelson Research & Development Company, Martin A Voet, November 2, 1976: US03989816 (154 worldwide citation)

There is disclosed an improved method for topically administering a physiologically active agent to a human or animal by dissolving an effective amount of the agent in a carrier containing suitable amounts of 1-substituted-azacycloheptan-2-one, as defined herein, and contacting the skin or other mem ...


9
Ming F Chan, Charles Gluchowski, David F Woodward: Intraocular pressure reducing 9,11-diacyl prostaglandins. Allergan, Martin A Voet, Robert J Baran, July 23, 1991: US05034413 (146 worldwide citation)

Certain 9,11-diacyl prostaglandins and their use for lowering intraocular pressure are disclosed herein.


10
Stephen Donovan: Method for treating cancer with a neurotoxin. Allergan Sales, Martin A Voet, Robert J Baran, Carlos A Fisher, October 31, 2000: US06139845 (138 worldwide citation)

A method for reducing a catecholamine secretion from a cholinergically innervated, functional chromaffin body, such as a paraganglioma or hyperplasic s adrenal medulla, by direct, local administration of a neurotoxin, such as a botulinum toxin.



Click the thumbnails below to visualize the patent trend.